Bioreductively activated stilbene prodrugs
AssigneeSiemens Aktiengesellschaft
InventorsPeter Davis, Matthew Naylor, Peter Thomson, Steven Everett, Michael Stratford, Peter Wardman
Life of this patent
Estimating the term…
Loading patent…
AssigneeSiemens Aktiengesellschaft
InventorsPeter Davis, Matthew Naylor, Peter Thomson, Steven Everett, Michael Stratford, Peter Wardman
Estimating the term…
A compound of formula (1), or a pharmaceutically acceptable salt thereof, wherein Ar is a substituted heteroaryl group bearing at least one nitro or azido group or is a group of formula (2) or (3); R1 is hydrogen, optionally substituted alkyl, optionally substituted aryl or optionally substituted heteroaryl; R2 is alkyl, alkoxy, thialkoxy or halo; R3, R4 and R5 are each independently alkyl, alkoxy, thialkoxy or halo with the proviso that at least two of R3, R4 or R5 are alkoxy; L is —OC(O)— or —OP(O)(OR6)—; n is 0 or 1; X is O, S or NR7; Y is hydrogen, alkyl, alkoxy, thialkoxy, halo, hydroxy or dihydrogenphosphate; R6 is hydrogen or alkyl; R7 is hydrogen or alkyl; R8 is hydrogen, alkoxy or dialkylaminoalkyl; R9 is optionally substituted alkyl; R10 is hydrogen, alkyl, alkoxy or dialkylaminoalkyl; R11, and R12 are independently hydrogen, alkyl, alkoxy, thialkoxy, amono alkylamino, dialkylamino, morpholino, alkylmorpholino, piperidino, alkylpiperidiono, piperazino, alkylpiperazino or 1-aziridinyl; and A, together with the carbon atoms to which it is fused, is an optionally substituted aryl or heteroaryl ring.
A compound of formula (1), or a pharmaceutically acceptable salt thereof:
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.